Moderna 'happy' with results from its kids vaccine trial, but is it enough for the FDA?

By POLITICO
| March 30, 2022

The company met its study goals, but experts are split over whether the data will be sufficient for the FDA.

Full story

#1

Physicians are in short supply. They are costly. Is the APP the answer to the CMO's workforce and budget challenges? ...

Amid the hype and promise, a growing tension is becoming clear: the reality of what AI can deliver versus what it can't. ...